Pharmacy providers may submit PA requests for BMN drugs requiring PA on the Portal, by fax, or by mail (but not using the STAT-PA system.) To obtain BMN PA, pharmacies are required to do the following: Documentation on the PA/BMNA form regarding the following may come from the pharmacy or the prescriber: Note: For appropriate reimbursement, pharmacy providers are required to submit claims with a "1" in the DAW/Product Selection Code, as appropriate
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults
Comp Biochem Physiol B: Comp Biochem
A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy
Tirzepatides Role in OSA Treatment Tirzepatide represents an additional treatment option for BetterNight patients with moderate-to-severe OSA and obesity
Semaglutide led to a sustained, clinically relevant reduction in body weight in participants with obesity, offering a promising pharmacologic option for long-term weight management (Wilding, New England Journal of Medicine )
